TrialJournal of clinical pharmacology2017

Population Pharmacokinetics of Brentuximab Vedotin in Patients With CD30-Expressing Hematologic Malignancies.

Hong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.